Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SLC29A1 | Q99808 | 5/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2218301 | 0.96 | KMT2A (0.46) | CA1CA2CA9CA12KMT2A | |
| SCHEMBL13220471 | 0.86 | SLC29A1 (0.50) | CA1CA2CA9CA12KMT2A | |
| SCHEMBL1817685 | 0.82 | GAA (0.50) | CA1CA2CA9KMT2AGAA | |
| SCHEMBL1031875 | 0.82 | CA12 (0.46) | CA1CA2CA9CA12MAPK1 | |
| SCHEMBL2219150 | 0.81 | SLC29A1 (0.49) | KMT2AGAAMEN1MAPK1SLC29A1 | |
| SCHEMBL1817811 | 0.79 | GAA (0.50) | CA1CA2CA9KMT2AGAA | |
| SCHEMBL1032559 | 0.77 | SLC29A1 (0.49) | KMT2AGAAMEN1MAPK1SLC29A1 | |
| SCHEMBL11764977 | 0.76 | LMNA (0.52) | CA1CA2CA9CA12SLC29A1 | |
| SCHEMBL11772001 | 0.76 | LMNA (0.52) | CA1CA2CA9CA12SLC29A1 | |
| SCHEMBL2843828 | 0.75 | CA12 (0.39) | CA1CA2CA9CA12SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2268610-B1 | METHOD FOR PRODUCING A COMPOUND WITH AT LEAST ONE AT LEAST MONOSUBSTITUTED AMINO GROUP | BOREALIS AGROLINZ MELAMINE (AT) | 2016-08-03 | — | — | EP | disclosed |
| US-8871842-B2 | Method for producing a compound with at least one at least monosubstituted amino group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2014-10-28 | — | — | US | disclosed |
| US-20110178212-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-07-21 | — | — | US | disclosed |
| EP-2268610-A1 | METHOD FOR PRODUCING A COMPOUND WITH AT LEAST ONE AT LEAST MONOSUBSTITUTED AMINO GROUP | Borealis Agrolinz Melamine GmbH (AT) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009121603-A1 | METHOD FOR PRODUCING A COMPOUND WITH AT LEAST ONE AT LEAST MONOSUBSTITUTED AMINO GROUP | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178212-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | INMT, AADAT, AANAT | CA1 325/4885CA2 471/4885CA9 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.